nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—Penbutolol—coronary artery disease	0.335	1	CrCtD
Nadolol—ADRB1—coronary artery disease	0.081	0.543	CbGaD
Nadolol—ADRB2—coronary artery disease	0.0681	0.457	CbGaD
Nadolol—Bupranolol—Gemfibrozil—coronary artery disease	0.0666	0.283	CrCrCtD
Nadolol—ADRB3—Timolol—coronary artery disease	0.0389	0.205	CbGbCtD
Nadolol—Levobunolol—Timolol—coronary artery disease	0.0341	0.145	CrCrCtD
Nadolol—Penbutolol—Timolol—coronary artery disease	0.031	0.132	CrCrCtD
Nadolol—Carteolol—Penbutolol—coronary artery disease	0.029	0.123	CrCrCtD
Nadolol—Levobunolol—Penbutolol—coronary artery disease	0.029	0.123	CrCrCtD
Nadolol—Bupranolol—Timolol—coronary artery disease	0.0247	0.105	CrCrCtD
Nadolol—ADRB2—Penbutolol—coronary artery disease	0.0226	0.119	CbGbCtD
Nadolol—ADRB1—Penbutolol—coronary artery disease	0.0222	0.117	CbGbCtD
Nadolol—Bupranolol—Penbutolol—coronary artery disease	0.021	0.0891	CrCrCtD
Nadolol—ADRB2—Timolol—coronary artery disease	0.0159	0.0838	CbGbCtD
Nadolol—ADRB1—Timolol—coronary artery disease	0.0157	0.0825	CbGbCtD
Nadolol—ABCB1—Ticagrelor—coronary artery disease	0.00973	0.0512	CbGbCtD
Nadolol—ABCB1—Clopidogrel—coronary artery disease	0.00601	0.0316	CbGbCtD
Nadolol—ABCB1—Perindopril—coronary artery disease	0.00601	0.0316	CbGbCtD
Nadolol—ABCB1—Pitavastatin—coronary artery disease	0.00525	0.0277	CbGbCtD
Nadolol—ABCB1—Telmisartan—coronary artery disease	0.00525	0.0277	CbGbCtD
Nadolol—ABCB1—Enalapril—coronary artery disease	0.00498	0.0262	CbGbCtD
Nadolol—ABCB1—Lisinopril—coronary artery disease	0.00498	0.0262	CbGbCtD
Nadolol—ABCB1—Timolol—coronary artery disease	0.00423	0.0223	CbGbCtD
Nadolol—ABCB1—Ezetimibe—coronary artery disease	0.00387	0.0204	CbGbCtD
Nadolol—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00377	0.0199	CbGbCtD
Nadolol—ABCB1—Captopril—coronary artery disease	0.00373	0.0196	CbGbCtD
Nadolol—ABCB1—Simvastatin—coronary artery disease	0.0036	0.019	CbGbCtD
Nadolol—ABCB1—Pravastatin—coronary artery disease	0.00352	0.0185	CbGbCtD
Nadolol—ABCB1—Lovastatin—coronary artery disease	0.00352	0.0185	CbGbCtD
Nadolol—ABCB1—Atorvastatin—coronary artery disease	0.00321	0.0169	CbGbCtD
Nadolol—ABCB1—Losartan—coronary artery disease	0.00294	0.0155	CbGbCtD
Nadolol—Treprostinil—P2RY12—coronary artery disease	0.000478	0.27	CrCbGaD
Nadolol—Pirbuterol—ADRB1—coronary artery disease	0.000142	0.0806	CrCbGaD
Nadolol—Levobunolol—ADRB1—coronary artery disease	0.000127	0.0719	CrCbGaD
Nadolol—Pirbuterol—ADRB2—coronary artery disease	0.00012	0.0678	CrCbGaD
Nadolol—Carteolol—ADRB1—coronary artery disease	0.000108	0.0611	CrCbGaD
Nadolol—Levobunolol—ADRB2—coronary artery disease	0.000107	0.0604	CrCbGaD
Nadolol—Bupranolol—ADRB1—coronary artery disease	9.18e-05	0.052	CrCbGaD
Nadolol—Carteolol—ADRB2—coronary artery disease	9.08e-05	0.0514	CrCbGaD
Nadolol—Salbutamol—ADRB1—coronary artery disease	8.63e-05	0.0488	CrCbGaD
Nadolol—Penbutolol—ADRB1—coronary artery disease	8.4e-05	0.0475	CrCbGaD
Nadolol—Bupranolol—ADRB2—coronary artery disease	7.72e-05	0.0437	CrCbGaD
Nadolol—Salbutamol—ADRB2—coronary artery disease	7.26e-05	0.0411	CrCbGaD
Nadolol—Penbutolol—ADRB2—coronary artery disease	7.06e-05	0.04	CrCbGaD
Nadolol—Pindolol—ADRB1—coronary artery disease	6.05e-05	0.0343	CrCbGaD
Nadolol—Pindolol—ADRB2—coronary artery disease	5.09e-05	0.0288	CrCbGaD
Nadolol—Alopecia—Lisinopril—coronary artery disease	3.13e-05	0.000493	CcSEcCtD
Nadolol—Hyperhidrosis—Losartan—coronary artery disease	3.13e-05	0.000492	CcSEcCtD
Nadolol—Dyspepsia—Captopril—coronary artery disease	3.13e-05	0.000492	CcSEcCtD
Nadolol—Constipation—Telmisartan—coronary artery disease	3.13e-05	0.000492	CcSEcCtD
Nadolol—Pain—Telmisartan—coronary artery disease	3.13e-05	0.000492	CcSEcCtD
Nadolol—Insomnia—Perindopril—coronary artery disease	3.12e-05	0.000491	CcSEcCtD
Nadolol—Diarrhoea—Clopidogrel—coronary artery disease	3.12e-05	0.000491	CcSEcCtD
Nadolol—Asthenia—Eplerenone—coronary artery disease	3.12e-05	0.000491	CcSEcCtD
Nadolol—Diarrhoea—Lovastatin—coronary artery disease	3.1e-05	0.000488	CcSEcCtD
Nadolol—Paraesthesia—Perindopril—coronary artery disease	3.1e-05	0.000488	CcSEcCtD
Nadolol—Decreased appetite—Captopril—coronary artery disease	3.09e-05	0.000486	CcSEcCtD
Nadolol—Anorexia—Losartan—coronary artery disease	3.08e-05	0.000486	CcSEcCtD
Nadolol—Nausea—Acetylsalicylic acid—coronary artery disease	3.08e-05	0.000486	CcSEcCtD
Nadolol—Pruritus—Eplerenone—coronary artery disease	3.08e-05	0.000484	CcSEcCtD
Nadolol—Dyspnoea—Perindopril—coronary artery disease	3.08e-05	0.000484	CcSEcCtD
Nadolol—Body temperature increased—Niacin—coronary artery disease	3.08e-05	0.000484	CcSEcCtD
Nadolol—Dizziness—Fenofibrate—coronary artery disease	3.07e-05	0.000483	CcSEcCtD
Nadolol—Fatigue—Captopril—coronary artery disease	3.06e-05	0.000482	CcSEcCtD
Nadolol—Syncope—Ramipril—coronary artery disease	3.05e-05	0.00048	CcSEcCtD
Nadolol—Asthenia—Simvastatin—coronary artery disease	3.04e-05	0.000479	CcSEcCtD
Nadolol—Diarrhoea—Ezetimibe—coronary artery disease	3.04e-05	0.000479	CcSEcCtD
Nadolol—Constipation—Captopril—coronary artery disease	3.04e-05	0.000478	CcSEcCtD
Nadolol—Flatulence—Lisinopril—coronary artery disease	3.04e-05	0.000478	CcSEcCtD
Nadolol—Dyspepsia—Perindopril—coronary artery disease	3.04e-05	0.000478	CcSEcCtD
Nadolol—Body temperature increased—Pravastatin—coronary artery disease	3.03e-05	0.000477	CcSEcCtD
Nadolol—Hypotension—Losartan—coronary artery disease	3.02e-05	0.000476	CcSEcCtD
Nadolol—Dizziness—Clopidogrel—coronary artery disease	3.02e-05	0.000475	CcSEcCtD
Nadolol—Paraesthesia—Furosemide—coronary artery disease	3.01e-05	0.000474	CcSEcCtD
Nadolol—Decreased appetite—Perindopril—coronary artery disease	3e-05	0.000472	CcSEcCtD
Nadolol—Pruritus—Simvastatin—coronary artery disease	3e-05	0.000472	CcSEcCtD
Nadolol—Dizziness—Lovastatin—coronary artery disease	3e-05	0.000472	CcSEcCtD
Nadolol—Loss of consciousness—Ramipril—coronary artery disease	2.99e-05	0.00047	CcSEcCtD
Nadolol—Syncope—Timolol—coronary artery disease	2.98e-05	0.000469	CcSEcCtD
Nadolol—Diarrhoea—Eplerenone—coronary artery disease	2.98e-05	0.000468	CcSEcCtD
Nadolol—Fatigue—Perindopril—coronary artery disease	2.97e-05	0.000468	CcSEcCtD
Nadolol—Cough—Ramipril—coronary artery disease	2.97e-05	0.000467	CcSEcCtD
Nadolol—Pain—Perindopril—coronary artery disease	2.95e-05	0.000464	CcSEcCtD
Nadolol—Constipation—Perindopril—coronary artery disease	2.95e-05	0.000464	CcSEcCtD
Nadolol—Vomiting—Fenofibrate—coronary artery disease	2.95e-05	0.000464	CcSEcCtD
Nadolol—Body temperature increased—Trandolapril—coronary artery disease	2.94e-05	0.000463	CcSEcCtD
Nadolol—Dizziness—Ezetimibe—coronary artery disease	2.94e-05	0.000463	CcSEcCtD
Nadolol—Body temperature increased—Enalapril—coronary artery disease	2.93e-05	0.000461	CcSEcCtD
Nadolol—Insomnia—Losartan—coronary artery disease	2.93e-05	0.000461	CcSEcCtD
Nadolol—Rash—Fenofibrate—coronary artery disease	2.93e-05	0.00046	CcSEcCtD
Nadolol—Dermatitis—Fenofibrate—coronary artery disease	2.92e-05	0.00046	CcSEcCtD
Nadolol—Loss of consciousness—Timolol—coronary artery disease	2.92e-05	0.00046	CcSEcCtD
Nadolol—Decreased appetite—Furosemide—coronary artery disease	2.92e-05	0.000459	CcSEcCtD
Nadolol—Vision blurred—Lisinopril—coronary artery disease	2.91e-05	0.000457	CcSEcCtD
Nadolol—Paraesthesia—Losartan—coronary artery disease	2.91e-05	0.000457	CcSEcCtD
Nadolol—Cough—Timolol—coronary artery disease	2.9e-05	0.000457	CcSEcCtD
Nadolol—Vomiting—Clopidogrel—coronary artery disease	2.9e-05	0.000456	CcSEcCtD
Nadolol—Diarrhoea—Simvastatin—coronary artery disease	2.9e-05	0.000456	CcSEcCtD
Nadolol—Chest pain—Ramipril—coronary artery disease	2.89e-05	0.000456	CcSEcCtD
Nadolol—Fatigue—Furosemide—coronary artery disease	2.89e-05	0.000455	CcSEcCtD
Nadolol—Body temperature increased—Telmisartan—coronary artery disease	2.89e-05	0.000455	CcSEcCtD
Nadolol—Dyspnoea—Losartan—coronary artery disease	2.89e-05	0.000454	CcSEcCtD
Nadolol—Vomiting—Lovastatin—coronary artery disease	2.88e-05	0.000453	CcSEcCtD
Nadolol—Dizziness—Eplerenone—coronary artery disease	2.88e-05	0.000453	CcSEcCtD
Nadolol—Rash—Clopidogrel—coronary artery disease	2.88e-05	0.000453	CcSEcCtD
Nadolol—Dermatitis—Clopidogrel—coronary artery disease	2.87e-05	0.000452	CcSEcCtD
Nadolol—Asthenia—Valsartan—coronary artery disease	2.87e-05	0.000452	CcSEcCtD
Nadolol—Hypertension—Timolol—coronary artery disease	2.87e-05	0.000452	CcSEcCtD
Nadolol—Pain—Furosemide—coronary artery disease	2.87e-05	0.000452	CcSEcCtD
Nadolol—Constipation—Furosemide—coronary artery disease	2.87e-05	0.000452	CcSEcCtD
Nadolol—Asthenia—Olmesartan—coronary artery disease	2.86e-05	0.00045	CcSEcCtD
Nadolol—Rash—Lovastatin—coronary artery disease	2.86e-05	0.00045	CcSEcCtD
Nadolol—Dermatitis—Lovastatin—coronary artery disease	2.85e-05	0.000449	CcSEcCtD
Nadolol—Dyspepsia—Losartan—coronary artery disease	2.85e-05	0.000448	CcSEcCtD
Nadolol—Pruritus—Valsartan—coronary artery disease	2.83e-05	0.000446	CcSEcCtD
Nadolol—Dry mouth—Ramipril—coronary artery disease	2.83e-05	0.000446	CcSEcCtD
Nadolol—Chest pain—Timolol—coronary artery disease	2.83e-05	0.000445	CcSEcCtD
Nadolol—Vomiting—Ezetimibe—coronary artery disease	2.83e-05	0.000445	CcSEcCtD
Nadolol—Pruritus—Olmesartan—coronary artery disease	2.82e-05	0.000444	CcSEcCtD
Nadolol—Decreased appetite—Losartan—coronary artery disease	2.81e-05	0.000443	CcSEcCtD
Nadolol—Body temperature increased—Captopril—coronary artery disease	2.81e-05	0.000442	CcSEcCtD
Nadolol—Dizziness—Simvastatin—coronary artery disease	2.8e-05	0.000441	CcSEcCtD
Nadolol—Rash—Ezetimibe—coronary artery disease	2.8e-05	0.000441	CcSEcCtD
Nadolol—Dermatitis—Ezetimibe—coronary artery disease	2.8e-05	0.000441	CcSEcCtD
Nadolol—Asthenia—Niacin—coronary artery disease	2.79e-05	0.000439	CcSEcCtD
Nadolol—Fatigue—Losartan—coronary artery disease	2.79e-05	0.000439	CcSEcCtD
Nadolol—Oedema—Ramipril—coronary artery disease	2.78e-05	0.000437	CcSEcCtD
Nadolol—Dry mouth—Timolol—coronary artery disease	2.77e-05	0.000436	CcSEcCtD
Nadolol—Pain—Losartan—coronary artery disease	2.77e-05	0.000436	CcSEcCtD
Nadolol—Constipation—Losartan—coronary artery disease	2.77e-05	0.000436	CcSEcCtD
Nadolol—Syncope—Lisinopril—coronary artery disease	2.77e-05	0.000435	CcSEcCtD
Nadolol—Vomiting—Eplerenone—coronary artery disease	2.77e-05	0.000435	CcSEcCtD
Nadolol—Nausea—Fenofibrate—coronary artery disease	2.76e-05	0.000434	CcSEcCtD
Nadolol—Pruritus—Niacin—coronary artery disease	2.75e-05	0.000433	CcSEcCtD
Nadolol—Asthenia—Pravastatin—coronary artery disease	2.75e-05	0.000433	CcSEcCtD
Nadolol—Rash—Eplerenone—coronary artery disease	2.74e-05	0.000432	CcSEcCtD
Nadolol—Dermatitis—Eplerenone—coronary artery disease	2.74e-05	0.000431	CcSEcCtD
Nadolol—Diarrhoea—Valsartan—coronary artery disease	2.74e-05	0.000431	CcSEcCtD
Nadolol—Shock—Ramipril—coronary artery disease	2.73e-05	0.00043	CcSEcCtD
Nadolol—Body temperature increased—Perindopril—coronary artery disease	2.73e-05	0.000429	CcSEcCtD
Nadolol—Diarrhoea—Olmesartan—coronary artery disease	2.72e-05	0.000429	CcSEcCtD
Nadolol—Oedema—Timolol—coronary artery disease	2.71e-05	0.000427	CcSEcCtD
Nadolol—Pruritus—Pravastatin—coronary artery disease	2.71e-05	0.000427	CcSEcCtD
Nadolol—Loss of consciousness—Lisinopril—coronary artery disease	2.71e-05	0.000427	CcSEcCtD
Nadolol—Nausea—Clopidogrel—coronary artery disease	2.71e-05	0.000426	CcSEcCtD
Nadolol—Vomiting—Simvastatin—coronary artery disease	2.69e-05	0.000424	CcSEcCtD
Nadolol—Cough—Lisinopril—coronary artery disease	2.69e-05	0.000424	CcSEcCtD
Nadolol—Nausea—Lovastatin—coronary artery disease	2.69e-05	0.000424	CcSEcCtD
Nadolol—Hyperhidrosis—Ramipril—coronary artery disease	2.68e-05	0.000422	CcSEcCtD
Nadolol—Rash—Simvastatin—coronary artery disease	2.67e-05	0.000421	CcSEcCtD
Nadolol—Dermatitis—Simvastatin—coronary artery disease	2.67e-05	0.00042	CcSEcCtD
Nadolol—Asthenia—Trandolapril—coronary artery disease	2.67e-05	0.00042	CcSEcCtD
Nadolol—Shock—Timolol—coronary artery disease	2.67e-05	0.00042	CcSEcCtD
Nadolol—Diarrhoea—Niacin—coronary artery disease	2.66e-05	0.000419	CcSEcCtD
Nadolol—Asthenia—Enalapril—coronary artery disease	2.66e-05	0.000418	CcSEcCtD
Nadolol—Body temperature increased—Furosemide—coronary artery disease	2.65e-05	0.000417	CcSEcCtD
Nadolol—Dizziness—Valsartan—coronary artery disease	2.65e-05	0.000417	CcSEcCtD
Nadolol—Anorexia—Ramipril—coronary artery disease	2.65e-05	0.000416	CcSEcCtD
Nadolol—Nausea—Ezetimibe—coronary artery disease	2.64e-05	0.000415	CcSEcCtD
Nadolol—Dizziness—Olmesartan—coronary artery disease	2.63e-05	0.000415	CcSEcCtD
Nadolol—Pruritus—Trandolapril—coronary artery disease	2.63e-05	0.000414	CcSEcCtD
Nadolol—Chest pain—Lisinopril—coronary artery disease	2.63e-05	0.000413	CcSEcCtD
Nadolol—Hyperhidrosis—Timolol—coronary artery disease	2.62e-05	0.000413	CcSEcCtD
Nadolol—Asthenia—Telmisartan—coronary artery disease	2.62e-05	0.000413	CcSEcCtD
Nadolol—Pruritus—Enalapril—coronary artery disease	2.62e-05	0.000413	CcSEcCtD
Nadolol—Diarrhoea—Pravastatin—coronary artery disease	2.62e-05	0.000413	CcSEcCtD
Nadolol—Hypotension—Ramipril—coronary artery disease	2.59e-05	0.000408	CcSEcCtD
Nadolol—Anorexia—Timolol—coronary artery disease	2.59e-05	0.000407	CcSEcCtD
Nadolol—Pruritus—Telmisartan—coronary artery disease	2.59e-05	0.000407	CcSEcCtD
Nadolol—Nausea—Eplerenone—coronary artery disease	2.58e-05	0.000407	CcSEcCtD
Nadolol—Dizziness—Niacin—coronary artery disease	2.57e-05	0.000405	CcSEcCtD
Nadolol—Dry mouth—Lisinopril—coronary artery disease	2.57e-05	0.000404	CcSEcCtD
Nadolol—Body temperature increased—Losartan—coronary artery disease	2.56e-05	0.000403	CcSEcCtD
Nadolol—Asthenia—Captopril—coronary artery disease	2.55e-05	0.000401	CcSEcCtD
Nadolol—Diarrhoea—Trandolapril—coronary artery disease	2.55e-05	0.000401	CcSEcCtD
Nadolol—Vomiting—Valsartan—coronary artery disease	2.54e-05	0.0004	CcSEcCtD
Nadolol—Diarrhoea—Enalapril—coronary artery disease	2.54e-05	0.000399	CcSEcCtD
Nadolol—Hypotension—Timolol—coronary artery disease	2.53e-05	0.000399	CcSEcCtD
Nadolol—Dizziness—Pravastatin—coronary artery disease	2.53e-05	0.000399	CcSEcCtD
Nadolol—Vomiting—Olmesartan—coronary artery disease	2.53e-05	0.000399	CcSEcCtD
Nadolol—Rash—Valsartan—coronary artery disease	2.52e-05	0.000397	CcSEcCtD
Nadolol—Dermatitis—Valsartan—coronary artery disease	2.52e-05	0.000397	CcSEcCtD
Nadolol—Nausea—Simvastatin—coronary artery disease	2.52e-05	0.000396	CcSEcCtD
Nadolol—Oedema—Lisinopril—coronary artery disease	2.52e-05	0.000396	CcSEcCtD
Nadolol—Pruritus—Captopril—coronary artery disease	2.51e-05	0.000396	CcSEcCtD
Nadolol—Rash—Olmesartan—coronary artery disease	2.51e-05	0.000395	CcSEcCtD
Nadolol—Insomnia—Ramipril—coronary artery disease	2.51e-05	0.000395	CcSEcCtD
Nadolol—Dermatitis—Olmesartan—coronary artery disease	2.51e-05	0.000395	CcSEcCtD
Nadolol—Diarrhoea—Telmisartan—coronary artery disease	2.5e-05	0.000394	CcSEcCtD
Nadolol—Paraesthesia—Ramipril—coronary artery disease	2.49e-05	0.000392	CcSEcCtD
Nadolol—Shock—Lisinopril—coronary artery disease	2.48e-05	0.00039	CcSEcCtD
Nadolol—Asthenia—Perindopril—coronary artery disease	2.48e-05	0.00039	CcSEcCtD
Nadolol—Dyspnoea—Ramipril—coronary artery disease	2.47e-05	0.000389	CcSEcCtD
Nadolol—Vomiting—Niacin—coronary artery disease	2.47e-05	0.000389	CcSEcCtD
Nadolol—Dizziness—Trandolapril—coronary artery disease	2.46e-05	0.000387	CcSEcCtD
Nadolol—Insomnia—Timolol—coronary artery disease	2.45e-05	0.000386	CcSEcCtD
Nadolol—Rash—Niacin—coronary artery disease	2.45e-05	0.000386	CcSEcCtD
Nadolol—Dermatitis—Niacin—coronary artery disease	2.45e-05	0.000386	CcSEcCtD
Nadolol—Dizziness—Enalapril—coronary artery disease	2.45e-05	0.000386	CcSEcCtD
Nadolol—Dyspepsia—Ramipril—coronary artery disease	2.44e-05	0.000385	CcSEcCtD
Nadolol—Pruritus—Perindopril—coronary artery disease	2.44e-05	0.000384	CcSEcCtD
Nadolol—Paraesthesia—Timolol—coronary artery disease	2.44e-05	0.000383	CcSEcCtD
Nadolol—Vomiting—Pravastatin—coronary artery disease	2.44e-05	0.000383	CcSEcCtD
Nadolol—Hyperhidrosis—Lisinopril—coronary artery disease	2.43e-05	0.000383	CcSEcCtD
Nadolol—Diarrhoea—Captopril—coronary artery disease	2.43e-05	0.000383	CcSEcCtD
Nadolol—Dyspnoea—Timolol—coronary artery disease	2.42e-05	0.000381	CcSEcCtD
Nadolol—Dizziness—Telmisartan—coronary artery disease	2.42e-05	0.00038	CcSEcCtD
Nadolol—Rash—Pravastatin—coronary artery disease	2.42e-05	0.00038	CcSEcCtD
Nadolol—Dermatitis—Pravastatin—coronary artery disease	2.41e-05	0.00038	CcSEcCtD
Nadolol—Decreased appetite—Ramipril—coronary artery disease	2.41e-05	0.00038	CcSEcCtD
Nadolol—Asthenia—Furosemide—coronary artery disease	2.41e-05	0.000379	CcSEcCtD
Nadolol—Anorexia—Lisinopril—coronary artery disease	2.4e-05	0.000378	CcSEcCtD
Nadolol—Fatigue—Ramipril—coronary artery disease	2.39e-05	0.000377	CcSEcCtD
Nadolol—Dyspepsia—Timolol—coronary artery disease	2.39e-05	0.000376	CcSEcCtD
Nadolol—Nausea—Valsartan—coronary artery disease	2.38e-05	0.000374	CcSEcCtD
Nadolol—Pruritus—Furosemide—coronary artery disease	2.37e-05	0.000374	CcSEcCtD
Nadolol—Constipation—Ramipril—coronary artery disease	2.37e-05	0.000374	CcSEcCtD
Nadolol—Nausea—Olmesartan—coronary artery disease	2.37e-05	0.000372	CcSEcCtD
Nadolol—Vomiting—Trandolapril—coronary artery disease	2.37e-05	0.000372	CcSEcCtD
Nadolol—Diarrhoea—Perindopril—coronary artery disease	2.36e-05	0.000372	CcSEcCtD
Nadolol—Decreased appetite—Timolol—coronary artery disease	2.36e-05	0.000371	CcSEcCtD
Nadolol—Vomiting—Enalapril—coronary artery disease	2.36e-05	0.000371	CcSEcCtD
Nadolol—Hypotension—Lisinopril—coronary artery disease	2.35e-05	0.00037	CcSEcCtD
Nadolol—Dizziness—Captopril—coronary artery disease	2.35e-05	0.00037	CcSEcCtD
Nadolol—Rash—Trandolapril—coronary artery disease	2.35e-05	0.000369	CcSEcCtD
Nadolol—Dermatitis—Trandolapril—coronary artery disease	2.34e-05	0.000369	CcSEcCtD
Nadolol—Fatigue—Timolol—coronary artery disease	2.34e-05	0.000368	CcSEcCtD
Nadolol—Rash—Enalapril—coronary artery disease	2.34e-05	0.000368	CcSEcCtD
Nadolol—Dermatitis—Enalapril—coronary artery disease	2.33e-05	0.000367	CcSEcCtD
Nadolol—Vomiting—Telmisartan—coronary artery disease	2.32e-05	0.000366	CcSEcCtD
Nadolol—Asthenia—Losartan—coronary artery disease	2.32e-05	0.000366	CcSEcCtD
Nadolol—Pain—Timolol—coronary artery disease	2.32e-05	0.000365	CcSEcCtD
Nadolol—Nausea—Niacin—coronary artery disease	2.31e-05	0.000364	CcSEcCtD
Nadolol—Rash—Telmisartan—coronary artery disease	2.3e-05	0.000363	CcSEcCtD
Nadolol—Dermatitis—Telmisartan—coronary artery disease	2.3e-05	0.000362	CcSEcCtD
Nadolol—Diarrhoea—Furosemide—coronary artery disease	2.29e-05	0.000361	CcSEcCtD
Nadolol—Pruritus—Losartan—coronary artery disease	2.29e-05	0.00036	CcSEcCtD
Nadolol—Dizziness—Perindopril—coronary artery disease	2.28e-05	0.000359	CcSEcCtD
Nadolol—Insomnia—Lisinopril—coronary artery disease	2.28e-05	0.000358	CcSEcCtD
Nadolol—Nausea—Pravastatin—coronary artery disease	2.28e-05	0.000358	CcSEcCtD
Nadolol—Paraesthesia—Lisinopril—coronary artery disease	2.26e-05	0.000356	CcSEcCtD
Nadolol—Vomiting—Captopril—coronary artery disease	2.26e-05	0.000356	CcSEcCtD
Nadolol—Dyspnoea—Lisinopril—coronary artery disease	2.24e-05	0.000353	CcSEcCtD
Nadolol—Rash—Captopril—coronary artery disease	2.24e-05	0.000353	CcSEcCtD
Nadolol—Dermatitis—Captopril—coronary artery disease	2.24e-05	0.000352	CcSEcCtD
Nadolol—Dizziness—Furosemide—coronary artery disease	2.22e-05	0.000349	CcSEcCtD
Nadolol—Dyspepsia—Lisinopril—coronary artery disease	2.22e-05	0.000349	CcSEcCtD
Nadolol—Diarrhoea—Losartan—coronary artery disease	2.21e-05	0.000349	CcSEcCtD
Nadolol—Nausea—Trandolapril—coronary artery disease	2.21e-05	0.000348	CcSEcCtD
Nadolol—Nausea—Enalapril—coronary artery disease	2.2e-05	0.000346	CcSEcCtD
Nadolol—Vomiting—Perindopril—coronary artery disease	2.19e-05	0.000345	CcSEcCtD
Nadolol—Body temperature increased—Ramipril—coronary artery disease	2.19e-05	0.000345	CcSEcCtD
Nadolol—Decreased appetite—Lisinopril—coronary artery disease	2.19e-05	0.000344	CcSEcCtD
Nadolol—Rash—Perindopril—coronary artery disease	2.18e-05	0.000342	CcSEcCtD
Nadolol—Dermatitis—Perindopril—coronary artery disease	2.17e-05	0.000342	CcSEcCtD
Nadolol—Nausea—Telmisartan—coronary artery disease	2.17e-05	0.000342	CcSEcCtD
Nadolol—Fatigue—Lisinopril—coronary artery disease	2.17e-05	0.000342	CcSEcCtD
Nadolol—Pain—Lisinopril—coronary artery disease	2.15e-05	0.000339	CcSEcCtD
Nadolol—Constipation—Lisinopril—coronary artery disease	2.15e-05	0.000339	CcSEcCtD
Nadolol—Body temperature increased—Timolol—coronary artery disease	2.14e-05	0.000338	CcSEcCtD
Nadolol—Dizziness—Losartan—coronary artery disease	2.14e-05	0.000337	CcSEcCtD
Nadolol—Vomiting—Furosemide—coronary artery disease	2.13e-05	0.000336	CcSEcCtD
Nadolol—Rash—Furosemide—coronary artery disease	2.11e-05	0.000333	CcSEcCtD
Nadolol—Dermatitis—Furosemide—coronary artery disease	2.11e-05	0.000333	CcSEcCtD
Nadolol—Nausea—Captopril—coronary artery disease	2.11e-05	0.000332	CcSEcCtD
Nadolol—Vomiting—Losartan—coronary artery disease	2.06e-05	0.000324	CcSEcCtD
Nadolol—Nausea—Perindopril—coronary artery disease	2.05e-05	0.000323	CcSEcCtD
Nadolol—Rash—Losartan—coronary artery disease	2.04e-05	0.000321	CcSEcCtD
Nadolol—Dermatitis—Losartan—coronary artery disease	2.04e-05	0.000321	CcSEcCtD
Nadolol—Nausea—Furosemide—coronary artery disease	1.99e-05	0.000314	CcSEcCtD
Nadolol—Asthenia—Ramipril—coronary artery disease	1.99e-05	0.000313	CcSEcCtD
Nadolol—Body temperature increased—Lisinopril—coronary artery disease	1.99e-05	0.000313	CcSEcCtD
Nadolol—Pruritus—Ramipril—coronary artery disease	1.96e-05	0.000309	CcSEcCtD
Nadolol—Asthenia—Timolol—coronary artery disease	1.95e-05	0.000306	CcSEcCtD
Nadolol—Nausea—Losartan—coronary artery disease	1.92e-05	0.000303	CcSEcCtD
Nadolol—Pruritus—Timolol—coronary artery disease	1.92e-05	0.000302	CcSEcCtD
Nadolol—Diarrhoea—Ramipril—coronary artery disease	1.9e-05	0.000299	CcSEcCtD
Nadolol—Diarrhoea—Timolol—coronary artery disease	1.86e-05	0.000292	CcSEcCtD
Nadolol—Dizziness—Ramipril—coronary artery disease	1.84e-05	0.000289	CcSEcCtD
Nadolol—Asthenia—Lisinopril—coronary artery disease	1.81e-05	0.000284	CcSEcCtD
Nadolol—Dizziness—Timolol—coronary artery disease	1.79e-05	0.000282	CcSEcCtD
Nadolol—Pruritus—Lisinopril—coronary artery disease	1.78e-05	0.00028	CcSEcCtD
Nadolol—Vomiting—Ramipril—coronary artery disease	1.76e-05	0.000278	CcSEcCtD
Nadolol—Rash—Ramipril—coronary artery disease	1.75e-05	0.000275	CcSEcCtD
Nadolol—Dermatitis—Ramipril—coronary artery disease	1.75e-05	0.000275	CcSEcCtD
Nadolol—Vomiting—Timolol—coronary artery disease	1.72e-05	0.000272	CcSEcCtD
Nadolol—Diarrhoea—Lisinopril—coronary artery disease	1.72e-05	0.000271	CcSEcCtD
Nadolol—Rash—Timolol—coronary artery disease	1.71e-05	0.000269	CcSEcCtD
Nadolol—Dermatitis—Timolol—coronary artery disease	1.71e-05	0.000269	CcSEcCtD
Nadolol—Dizziness—Lisinopril—coronary artery disease	1.66e-05	0.000262	CcSEcCtD
Nadolol—Nausea—Ramipril—coronary artery disease	1.65e-05	0.000259	CcSEcCtD
Nadolol—Nausea—Timolol—coronary artery disease	1.61e-05	0.000254	CcSEcCtD
Nadolol—Vomiting—Lisinopril—coronary artery disease	1.6e-05	0.000252	CcSEcCtD
Nadolol—Rash—Lisinopril—coronary artery disease	1.59e-05	0.00025	CcSEcCtD
Nadolol—Dermatitis—Lisinopril—coronary artery disease	1.59e-05	0.00025	CcSEcCtD
Nadolol—Nausea—Lisinopril—coronary artery disease	1.49e-05	0.000235	CcSEcCtD
Nadolol—ADRB3—Signaling Pathways—FN1—coronary artery disease	3.34e-06	0.000131	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—F2—coronary artery disease	3.34e-06	0.000131	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HK1—coronary artery disease	3.33e-06	0.000131	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ABCG5—coronary artery disease	3.33e-06	0.000131	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SULT1A1—coronary artery disease	3.33e-06	0.000131	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GPX4—coronary artery disease	3.33e-06	0.000131	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6ST—coronary artery disease	3.33e-06	0.000131	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—JUNB—coronary artery disease	3.31e-06	0.00013	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NFKBIA—coronary artery disease	3.3e-06	0.00013	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL12—coronary artery disease	3.3e-06	0.00013	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—BDKRB2—coronary artery disease	3.3e-06	0.00013	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLCB1—coronary artery disease	3.3e-06	0.00013	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—POMC—coronary artery disease	3.3e-06	0.00013	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HADHA—coronary artery disease	3.29e-06	0.000129	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—F2—coronary artery disease	3.29e-06	0.000129	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6ST—coronary artery disease	3.27e-06	0.000129	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTA1—coronary artery disease	3.26e-06	0.000128	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	3.25e-06	0.000128	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—JUNB—coronary artery disease	3.24e-06	0.000127	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR7—coronary artery disease	3.23e-06	0.000127	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLCB1—coronary artery disease	3.23e-06	0.000127	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LPA—coronary artery disease	3.22e-06	0.000127	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—KIT—coronary artery disease	3.2e-06	0.000126	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR7—coronary artery disease	3.16e-06	0.000124	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLCB3—coronary artery disease	3.12e-06	0.000123	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOA5—coronary artery disease	3.09e-06	0.000121	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ITGAV—coronary artery disease	3.08e-06	0.000121	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GSK3B—coronary artery disease	3.07e-06	0.000121	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—KNG1—coronary artery disease	3.07e-06	0.000121	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—POMC—coronary artery disease	3.06e-06	0.00012	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CREB1—coronary artery disease	3.06e-06	0.00012	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AGTR1—coronary artery disease	3.05e-06	0.00012	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—POMC—coronary artery disease	3.05e-06	0.00012	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CREB1—coronary artery disease	3.05e-06	0.00012	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—P4HB—coronary artery disease	3.03e-06	0.000119	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ITGAV—coronary artery disease	3.01e-06	0.000118	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—KNG1—coronary artery disease	3e-06	0.000118	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL2—coronary artery disease	2.99e-06	0.000118	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—POMC—coronary artery disease	2.99e-06	0.000118	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CREB1—coronary artery disease	2.99e-06	0.000118	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AGTR1—coronary artery disease	2.99e-06	0.000117	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6R—coronary artery disease	2.98e-06	0.000117	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL10—coronary artery disease	2.98e-06	0.000117	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL2—coronary artery disease	2.98e-06	0.000117	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLG—coronary artery disease	2.97e-06	0.000117	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLA2G1B—coronary artery disease	2.97e-06	0.000117	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6R—coronary artery disease	2.97e-06	0.000117	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	2.97e-06	0.000117	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF1—coronary artery disease	2.93e-06	0.000115	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	2.93e-06	0.000115	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	2.92e-06	0.000115	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	2.92e-06	0.000115	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—MAPK1—coronary artery disease	2.92e-06	0.000115	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	2.91e-06	0.000114	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	2.9e-06	0.000114	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	2.86e-06	0.000112	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	2.86e-06	0.000112	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	2.85e-06	0.000112	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	2.84e-06	0.000112	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	2.82e-06	0.000111	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—VCAN—coronary artery disease	2.8e-06	0.00011	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	2.8e-06	0.00011	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	2.79e-06	0.00011	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	2.79e-06	0.00011	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—PIK3CA—coronary artery disease	2.79e-06	0.00011	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	2.78e-06	0.000109	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	2.78e-06	0.000109	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	2.78e-06	0.000109	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SERPINE1—coronary artery disease	2.78e-06	0.000109	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALDOA—coronary artery disease	2.78e-06	0.000109	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	2.76e-06	0.000109	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	2.76e-06	0.000108	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	2.72e-06	0.000107	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	2.72e-06	0.000107	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	2.72e-06	0.000107	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	2.72e-06	0.000107	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DCN—coronary artery disease	2.7e-06	0.000106	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—FGF2—coronary artery disease	2.69e-06	0.000106	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	2.66e-06	0.000105	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	2.66e-06	0.000105	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOS3—coronary artery disease	2.66e-06	0.000104	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	2.63e-06	0.000103	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALDH2—coronary artery disease	2.62e-06	0.000103	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	2.61e-06	0.000102	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	2.59e-06	0.000102	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	2.59e-06	0.000102	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—JAK2—coronary artery disease	2.58e-06	0.000101	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	2.57e-06	0.000101	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	2.57e-06	0.000101	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PIK3C2A—coronary artery disease	2.56e-06	0.000101	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LIPC—coronary artery disease	2.56e-06	0.000101	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP2C19—coronary artery disease	2.56e-06	0.000101	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HBA1—coronary artery disease	2.56e-06	0.000101	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	2.55e-06	0.0001	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOC3—coronary artery disease	2.54e-06	9.99e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	2.54e-06	9.97e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	2.53e-06	9.95e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—PIK3CA—coronary artery disease	2.53e-06	9.95e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	2.53e-06	9.94e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	2.53e-06	9.94e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LDLR—coronary artery disease	2.53e-06	9.93e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	2.51e-06	9.87e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	2.51e-06	9.87e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTT1—coronary artery disease	2.5e-06	9.81e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC9A1—coronary artery disease	2.5e-06	9.81e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	2.49e-06	9.78e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	2.49e-06	9.78e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	2.47e-06	9.72e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	2.47e-06	9.72e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GCLC—coronary artery disease	2.47e-06	9.7e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CETP—coronary artery disease	2.47e-06	9.7e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	2.46e-06	9.65e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SDC1—coronary artery disease	2.44e-06	9.59e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	2.43e-06	9.57e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	2.43e-06	9.57e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	2.42e-06	9.53e-05	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	2.42e-06	9.52e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	2.37e-06	9.32e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	2.37e-06	9.31e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL8—coronary artery disease	2.36e-06	9.26e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	2.36e-06	9.26e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	2.32e-06	9.1e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	2.31e-06	9.09e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PSMA6—coronary artery disease	2.3e-06	9.06e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PSMB5—coronary artery disease	2.3e-06	9.06e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	2.3e-06	9.06e-05	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—AKT1—coronary artery disease	2.28e-06	8.95e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	2.26e-06	8.9e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	2.26e-06	8.89e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—C3—coronary artery disease	2.26e-06	8.89e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CASP3—coronary artery disease	2.25e-06	8.86e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CTGF—coronary artery disease	2.25e-06	8.85e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—coronary artery disease	2.24e-06	8.81e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HMGCR—coronary artery disease	2.23e-06	8.77e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GOT2—coronary artery disease	2.23e-06	8.77e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	2.21e-06	8.7e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—C3—coronary artery disease	2.21e-06	8.69e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCND1—coronary artery disease	2.19e-06	8.63e-05	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	2.19e-06	8.6e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	2.16e-06	8.47e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	2.15e-06	8.44e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MMP9—coronary artery disease	2.13e-06	8.38e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	2.11e-06	8.29e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	2.1e-06	8.27e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	2.1e-06	8.27e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	2.1e-06	8.26e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	2.08e-06	8.18e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—AKT1—coronary artery disease	2.07e-06	8.12e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	2.06e-06	8.1e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	2.06e-06	8.09e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	2.06e-06	8.09e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLCB1—coronary artery disease	2.05e-06	8.07e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	2.05e-06	8.05e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	2.03e-06	8e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	2.02e-06	7.93e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	2.01e-06	7.9e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	2e-06	7.88e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ABCA1—coronary artery disease	1.99e-06	7.82e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	1.98e-06	7.8e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—F2—coronary artery disease	1.98e-06	7.8e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	1.98e-06	7.77e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	1.97e-06	7.73e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	1.96e-06	7.71e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	1.94e-06	7.63e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—F2—coronary artery disease	1.94e-06	7.63e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	1.93e-06	7.6e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GGT1—coronary artery disease	1.93e-06	7.57e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GOT1—coronary artery disease	1.93e-06	7.57e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	1.92e-06	7.54e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—VEGFA—coronary artery disease	1.91e-06	7.52e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	1.9e-06	7.47e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	1.86e-06	7.3e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	1.82e-06	7.16e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	1.81e-06	7.11e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	1.81e-06	7.11e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	1.78e-06	7.01e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	1.77e-06	6.95e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	1.77e-06	6.95e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	1.77e-06	6.95e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	1.76e-06	6.93e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TGFB1—coronary artery disease	1.76e-06	6.9e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	1.74e-06	6.84e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	1.73e-06	6.8e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTP1—coronary artery disease	1.73e-06	6.8e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	1.73e-06	6.8e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	1.72e-06	6.78e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MAPK1—coronary artery disease	1.72e-06	6.77e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.71e-06	6.74e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HMOX1—coronary artery disease	1.71e-06	6.71e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	1.7e-06	6.69e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	1.69e-06	6.65e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CAT—coronary artery disease	1.68e-06	6.62e-05	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.65e-06	6.5e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	1.65e-06	6.49e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOB—coronary artery disease	1.63e-06	6.43e-05	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.62e-06	6.36e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	1.62e-06	6.35e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	1.6e-06	6.28e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTM1—coronary artery disease	1.59e-06	6.25e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	1.58e-06	6.2e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	1.56e-06	6.15e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LPL—coronary artery disease	1.56e-06	6.14e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	1.54e-06	6.06e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	1.53e-06	6.02e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GPX1—coronary artery disease	1.52e-06	5.99e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	1.5e-06	5.9e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	1.5e-06	5.89e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PIK3CA—coronary artery disease	1.49e-06	5.88e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CD36—coronary artery disease	1.48e-06	5.83e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	1.47e-06	5.77e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.46e-06	5.76e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MTHFR—coronary artery disease	1.41e-06	5.52e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.4e-06	5.5e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	1.37e-06	5.38e-05	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.35e-06	5.31e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.34e-06	5.26e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AGT—coronary artery disease	1.34e-06	5.25e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.33e-06	5.23e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—coronary artery disease	1.32e-06	5.2e-05	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.32e-06	5.19e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.31e-06	5.15e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOE—coronary artery disease	1.31e-06	5.14e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.3e-06	5.12e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.3e-06	5.11e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOA1—coronary artery disease	1.29e-06	5.08e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.27e-06	5.01e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.26e-06	4.97e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	1.24e-06	4.86e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.23e-06	4.82e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AKT1—coronary artery disease	1.22e-06	4.8e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	1.2e-06	4.72e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARG—coronary artery disease	1.14e-06	4.48e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.14e-06	4.46e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—POMC—coronary artery disease	1.12e-06	4.42e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.11e-06	4.37e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.04e-06	4.1e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ALB—coronary artery disease	1.02e-06	4.03e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.02e-06	4.02e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.02e-06	4.01e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1e-06	3.93e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NOS3—coronary artery disease	9.8e-07	3.85e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS2—coronary artery disease	8.96e-07	3.52e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	8.87e-07	3.49e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	8.68e-07	3.41e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	7.85e-07	3.09e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	7.68e-07	3.02e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	7.25e-07	2.85e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	7.09e-07	2.79e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PIK3CA—coronary artery disease	5.51e-07	2.17e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AKT1—coronary artery disease	4.51e-07	1.77e-05	CbGpPWpGaD
